Related Experiment Video

Updated: Sep 14, 2026

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
12:24

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart

Published on: September 28, 2016

n-3 fatty acids and the risk of sudden cardiac death

J H Christensen1, E B Schmidt

  • 1Department of Nephrology, Aalborg Hospital, Denmark. jhc@dadlnet.dk

Lipids
|February 12, 2002
PubMed

Insights

Omega-3 fatty acids may reduce the risk of sudden cardiac death (SCD). Studies show these fatty acids improve heart rate variability (HRV), a key indicator for SCD risk prediction.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Preventive Medicine

Background:

  • Sudden cardiac death (SCD) is a leading cause of mortality, often presenting as the first symptom of coronary artery disease.
  • Predicting and preventing SCD remains a significant challenge in cardiovascular health.
  • Heart rate variability (HRV), assessed via 24-hour Holter monitoring, is a recognized predictor of SCD risk.

Purpose of the Study:

  • To investigate the impact of n-3 fatty acids on heart rate variability (HRV).
  • To evaluate the potential of n-3 fatty acids in mitigating SCD risk.
  • To provide further evidence supporting the cardioprotective effects of n-3 fatty acids.

Main Methods:

  • Utilized 24-hour Holter monitoring to record heart rate.
  • Analyzed heart rate variability (HRV) metrics.
  • Assessed the effects of n-3 fatty acid intake on HRV parameters.

Main Results:

  • n-3 fatty acids were shown to significantly increase heart rate variability (HRV).
  • The observed increase in HRV suggests a potential improvement in cardiac autonomic function.
  • Data indicates a positive correlation between n-3 fatty acid consumption and enhanced HRV.

Conclusions:

  • Increased intake of n-3 fatty acids may enhance HRV.
  • This finding supports the hypothesis that n-3 fatty acids can reduce the risk of sudden cardiac death (SCD).
  • n-3 fatty acids represent a promising nutritional strategy for cardiovascular risk reduction.

More Related Videos

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death08:26

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death

Published on: October 31, 2017

Related Concept Videos

Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...